Evidence map›Paper›PMID 30767670›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2019

Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.

Jennifer L Philip, Thomas M Murphy, David A Schreier, Sydney Stevens, Diana M Tabima, Margie Albrecht, Andrea L Frump, Timothy A Hacker, Tim Lahm, Naomi C Chesler

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Guidelines for in vivo mouse models of myocardial infarction.American journal of physiology. Heart and circulatory physiology · 2021
    Guideline
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.American journal of physiology. Heart and circulatory physiology · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. Hemodynamic assessment of diastolic function for experimental models.American journal of physiology. Heart and circulatory physiology · 2020
    Review
  12. Reply to TelloAmerican journal of respiratory and critical care medicine · 2020
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jennifer L PhilipDepartment of Biomedical Engineering, University of Wisconsin-Madison College of Engineering , Madison, Wisconsin.
Thomas M MurphyDepartment of Biomedical Engineering, University of Wisconsin-Madison College of Engineering , Madison, Wisconsin.
David A SchreierDepartment of Biomedical Engineering, University of Wisconsin-Madison College of Engineering , Madison, Wisconsin.
Sydney StevensDepartment of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Diana M TabimaDepartment of Biomedical Engineering, University of Wisconsin-Madison College of Engineering , Madison, Wisconsin.
Margie AlbrechtDepartment of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Andrea L FrumpDepartment of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Timothy A HackerDepartment of Medicine, University of Wisconsin-Madison , Madison, Wisconsin.
Tim LahmDepartment of Medicine, Indiana University School of Medicine , Indianapolis, Indiana.
Naomi C CheslerDepartment of Biomedical Engineering, University of Wisconsin-Madison College of Engineering , Madison, Wisconsin.
University of Wisconsin–Madison · USIndiana University School of MedicineIndiana University – Purdue University Indianapolis · USMadison Area Technical College · US

Funding

Vascular collagen accumulation & mechanical mechanisms in pulmonary hypertensionR01HL086939 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI CHESLER, NAOMI C · 2007 to 2016
$3.6M
Vascular Surgery Research Training ProgramT32HL110853 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MATSUMURA, JON STEVEN · 2012 to 2021
$2.6M
Hypoxia-mediated protective estrogen receptor signaling in pulmonary hypertensionI01BX002042 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI Tim Lahm · 2014 to 2026
–
BLRD VA I01 BX002042NHLBI NIH HHS R01 HL086939NHLBI NIH HHS T32 HL110853
6 · The paper itself

Abstract

Left heart failure (LHF) is the most common cause of pulmonary hypertension, which confers an increase in morbidity and mortality in this context. Pulmonary vascular resistance has prognostic value in LHF, but otherwise the mechanical consequences of LHF for the pulmonary vasculature and right ventricle (RV) remain unknown. We sought to investigate mechanical mechanisms of pulmonary vascular and RV dysfunction in a rodent model of LHF to address the knowledge gaps in understanding disease pathophysiology. LHF was created using a left anterior descending artery ligation to cause myocardial infarction (MI) in mice. Sham animals underwent thoracotomy alone. Echocardiography demonstrated increased left ventricle (LV) volumes and decreased ejection fraction at 4 wk post-MI that did not normalize by 12 wk post-MI. Elevation of LV diastolic pressure and RV systolic pressure at 12 wk post-MI demonstrated pulmonary hypertension (PH) due to LHF. There was increased pulmonary arterial elastance and pulmonary vascular resistance associated with perivascular fibrosis without other remodeling. There was also RV contractile dysfunction with a 35% decrease in RV end-systolic elastance and 66% decrease in ventricular-vascular coupling. In this model of PH due to LHF with reduced ejection fraction, pulmonary fibrosis contributes to increased RV afterload, and loss of RV contractility contributes to RV dysfunction. These are key pathologic features of human PH secondary to LHF. In the future, novel therapeutic strategies aimed at preventing pulmonary vascular mechanical changes and RV dysfunction in the context of LHF can be tested using this model.

Indexed as

Pulmonary CirculationVentricular Function, LeftVentricular Function, RightAnimalsDisease Models, AnimalFibrosisHeart FailureMaleMice, Inbred C57BLMyocardial InfarctionPulmonary Arterial HypertensionPulmonary ArteryStroke VolumeVascular RemodelingVentricular Dysfunction, LeftVentricular Dysfunction, Rightheart failurepulmonary vascular remodelingright ventricle dysfunctionsecondary pulmonary hypertensionventricular-vascular coupling

Identifiers

PMID30767670
PMCPMC6580389
OpenAlexW2914832736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.